These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


56 related items for PubMed ID: 8325255

  • 1. Effects of hyperparathyroidism on blood lead concentrations in man.
    Osterloh JD, Clark OH.
    Environ Res; 1993 Jul; 62(1):1-6. PubMed ID: 8325255
    [Abstract] [Full Text] [Related]

  • 2. Effects of parathyroidectomy on lead mobilization from bone in patients with primary hyperparathyroidism.
    Osterode W, Winker R, Bieglmayer C, Vierhapper H.
    Bone; 2004 Oct; 35(4):942-7. PubMed ID: 15454101
    [Abstract] [Full Text] [Related]

  • 3. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
    Rostaing L, Moreau-Gaudry X, Baron E, Cisterne JM, Monroziès-Bernadet P, Durand D.
    Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
    [Abstract] [Full Text] [Related]

  • 4. Spermatogenesis after parathyroidectomy in patients with symptomatic secondary hyperparathyroidism.
    Chou FF, Lee CH, Lee CT, Huang FJ, Hsu KL.
    J Am Coll Surg; 2003 Jun; 196(6):854-8. PubMed ID: 12788420
    [Abstract] [Full Text] [Related]

  • 5. [Changes in calcium metabolism after parathyroidectomy in primary hyperparathyroidism].
    Berczi C, Balogh A, Balázs G, Lukács G.
    Orv Hetil; 2002 Mar 24; 143(12):597-600. PubMed ID: 11963396
    [Abstract] [Full Text] [Related]

  • 6. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis.
    Chow TL, Chan TT, Ho YW, Lam SH.
    Arch Surg; 2007 Jul 24; 142(7):644-8. PubMed ID: 17638802
    [Abstract] [Full Text] [Related]

  • 7. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
    Beyer TD, Solorzano CC, Prinz RA, Babu A, Nilubol N, Patel S.
    Surgery; 2007 Jun 24; 141(6):777-83. PubMed ID: 17560254
    [Abstract] [Full Text] [Related]

  • 8. Observations on the effect of parathyroid hormone on environmental blood lead concentrations in humans.
    Osterloh JD.
    Environ Res; 1991 Feb 24; 54(1):8-16. PubMed ID: 2004638
    [Abstract] [Full Text] [Related]

  • 9. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
    Pulvirenti D, Aikaterini T, Campagna A, Ignaccolo L, Giustolisi N, Costa E.
    Clin Ter; 2008 Feb 24; 159(5):307-10. PubMed ID: 18998031
    [Abstract] [Full Text] [Related]

  • 10. Persistent hyperparathyroidism after kidney transplantation requiring parathyroidectomy.
    Evenepoel P, Kuypers D, Maes B, Messiaen T, Vanrenterghem Y.
    Acta Otorhinolaryngol Belg; 2001 Feb 24; 55(2):177-86. PubMed ID: 11441477
    [Abstract] [Full Text] [Related]

  • 11. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
    Räkel A, Brossard JH, Patenaude JV, Albert C, Nassif E, Cantor T, Rousseau L, D'Amour P.
    Clin Endocrinol (Oxf); 2005 Jun 24; 62(6):721-7. PubMed ID: 15943835
    [Abstract] [Full Text] [Related]

  • 12. Chelated lead in relation to lead in bone and ALAD genotype.
    Gerhardsson L, Börjesson J, Mattsson S, Schütz A, Skerfving S.
    Environ Res; 1999 May 24; 80(4):389-98. PubMed ID: 10330313
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD, Luck ML, Laughlin NK, Smith DR.
    Toxicol Appl Pharmacol; 1999 Dec 15; 161(3):283-93. PubMed ID: 10620486
    [Abstract] [Full Text] [Related]

  • 14. [Hormonal interactions of parathormone and calcium metabolism].
    Kovács L.
    Orv Hetil; 2003 Jan 05; 144(1):3-12. PubMed ID: 12635347
    [Abstract] [Full Text] [Related]

  • 15. The effects of CaNa(2)EDTA on brain lead mobilization in rodents determined using a stable lead isotope tracer.
    Seaton CL, Lasman J, Smith DR.
    Toxicol Appl Pharmacol; 1999 Sep 15; 159(3):153-60. PubMed ID: 10486301
    [Abstract] [Full Text] [Related]

  • 16. RenaGel efficacy in severe secondary hyperparathyroidism.
    Castro R, Herman A, Ferreira C, Travassos F, Nunes-Azevedo J, Oliveira M.
    Nefrologia; 2002 Sep 15; 22(5):448-55. PubMed ID: 12497746
    [Abstract] [Full Text] [Related]

  • 17. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G.
    J Am Geriatr Soc; 2007 May 15; 55(5):752-7. PubMed ID: 17493196
    [Abstract] [Full Text] [Related]

  • 18. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
    Toussaint ND, Polkinghorne KR, Kerr PG, Somerville CA, Agar JW.
    Hemodial Int; 2007 Apr 15; 11(2):217-24. PubMed ID: 17403174
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Normalization of intraoperative parathyroid hormone does not predict normal postoperative parathyroid hormone levels.
    Starr FL, DeCresce R, Prinz RA.
    Surgery; 2000 Dec 15; 128(6):930-5;discussion 935-6. PubMed ID: 11114626
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.